MEGAN BIERMAN: Open Payments
NPI 1831528405 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$104 in 5 payments from 4 companies in 2025. Trend: 2023 $1,910 · 2024 $136 · 2025 $104
Food & beverage: $104
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $44 |
| ABBVIE INC. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: ARISTADA, VRAYLAR, CAPLYTA, FANAPT.
Industry payments across IN — which companies pay providers there.
